Promino Nutritional Sciences Inc.
MUSL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 95.90K | 8.50K | 15.70K | 60.60K | 155.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 95.90K | 8.50K | 15.70K | 60.60K | 155.80K |
| Cost of Revenue | 55.60K | 19.10K | -300.00 | 651.80K | 677.10K |
| Gross Profit | 40.40K | -10.60K | 16.00K | -591.20K | -521.20K |
| SG&A Expenses | 1.38M | 2.21M | 2.28M | 2.47M | -708.90K |
| Depreciation & Amortization | -- | -- | -- | 5.40K | 5.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.47M | 2.23M | 2.29M | 3.13M | -25.90K |
| Operating Income | -1.38M | -2.23M | -2.27M | -3.07M | 181.70K |
| Income Before Tax | -1.35M | -1.99M | -2.24M | -2.94M | 137.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.35M | -1.99M | -2.24M | -2.94M | 137.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.35M | -1.99M | -2.24M | -2.94M | 137.20K |
| EBIT | -1.38M | -2.23M | -2.27M | -3.07M | 181.70K |
| EBITDA | -1.37M | -2.22M | -2.27M | -3.07M | 186.20K |
| EPS Basic | -0.01 | -0.03 | -0.04 | -0.07 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.03 | -0.05 | 0.00 |
| EPS Diluted | -0.01 | -0.03 | -0.04 | -0.07 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.03 | -0.05 | 0.00 |
| Average Basic Shares Outstanding | 99.93M | 64.83M | 52.88M | 39.98M | 114.85M |
| Average Diluted Shares Outstanding | 99.93M | 64.83M | 52.88M | 39.98M | 114.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
